News Focus
News Focus
Followers 47
Posts 23815
Boards Moderated 0
Alias Born 09/16/2012

Re: leighlogan post# 769973

Sunday, 06/01/2025 9:58:35 AM

Sunday, June 01, 2025 9:58:35 AM

Post# of 828287
Oh my, the good doctor is dipping his toes into fundamentals! Bravo! Unfortunately it rarely ever works the way he’s figuring. Debt is never “fully cleared” in biotech land. IF there’s actually anything for real about DCVAX, the company will continue raising money to pursue research, other trials, and indications as it’ll take years for GBM revenue to get up to speed to actually turn a profit. At some point usually what happens is the financiers determined the stock could see more action after a reverse split with the hopes of raising more money and increasing the authorized count. Caravello also neglects to mention ( as so many do) that the company apparently in charge of all manufacturing and operations is the CEO-CFO’s private overseas CDMO. I can’t imagine that will end well for retail shareholders unless something radically changes. 🤷‍♀️

The key to great management isn’t so much the shares outstanding they’ve released but the price at which those shares were sold as the years go by.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News